ECOSYSTEM

Southeast Asia presents exceptional opportunities for advancing stem cell and regenerative medicine, combining access to world-class scientific innovation, a large and diverse patient population, and rapidly expanding healthcare systems. However, the region still lacks the integrated infrastructure needed to translate these advantages into globally competitive therapies and biomanufacturing capabilities. SABC-HLP addresses this gap through five interconnected pillars that establish a complete innovation ecosystem—from biological resources and technology platforms to clinical translation, regional deployment, and sustainable healthcare impact.

Building Southeast Asia's Stem Cell Innovation Ecosystem

1. Biobank Network – The Foundation

Builds a regional network of standardized stem cell, tissue, blood, and genomic biobanks. Provides the high-quality biological resources that power research, manufacturing, and clinical innovation.

2. Manufacturing & Standardization -The Engine

Develops GMP-based manufacturing, quality systems, and standardized protocols that convert scientific discoveries into safe, reproducible, and scalable cell and gene therapy products.

3. Global Partnerships & Technology Transfer – The Accelerator

4. Clinical Translation – The Validation

Advances new therapies through clinical studies, regulatory pathways, and hospital collaborations to establish safety, efficacy, and clinical value.

5. Regional Deployment & Commercialization – The Impact

Expands validated technologies across Southeast Asia through healthcare partnerships, industrial production, and commercialization, ensuring that innovative therapies become accessible to patients while creating sustainable economic value.

Read More →Technololy transfer

Read More →Therapy R&D Network

Read More →ARB Network

Read More → Bio Cryobanking

Connects SABC-HLP with leading international institutions, biotechnology companies, and industry partners to acquire advanced technologies, transfer know-how, develop talent, and accelerate innovation.